Cargando…
The cannabinoid receptor 1 is involved in renal fibrosis during chronic allograft dysfunction: Proof of concept
Chronic allograft dysfunction (CAD), defined as the replacement of functional renal tissue by extracellular matrix proteins, remains the first cause of graft loss. The aim of our study was to explore the potential role of the cannabinoid receptor 1 (CB1) during CAD. We retrospectively quantified CB1...
Autores principales: | Dao, Myriam, Lecru, Lola, Vandermeersch, Sophie, Ferreira, Mélanie, Ferlicot, Sophie, Posseme, Katia, Dürrbach, Antoine, Hermeziu, Bogdan, Mussini, Charlotte, Chatziantoniou, Christos, François, Hélène |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815790/ https://www.ncbi.nlm.nih.gov/pubmed/31469511 http://dx.doi.org/10.1111/jcmm.14570 |
Ejemplares similares
-
Usefulness of morphometric image analysis with Sirius Red to assess interstitial fibrosis after renal transplantation from uncontrolled circulatory death donors
por: Dao, Myriam, et al.
Publicado: (2020) -
BK virus-associated collecting duct carcinoma of the renal allograft in a kidney-pancreas allograft recipient
por: Dao, Myriam, et al.
Publicado: (2018) -
IL-15 Prevents Renal Fibrosis by Inhibiting Collagen Synthesis: A New Pathway in Chronic Kidney Disease?
por: Devocelle, Aurore, et al.
Publicado: (2021) -
Cannabinoid treatment for autism: a proof-of-concept randomized trial
por: Aran, Adi, et al.
Publicado: (2021) -
Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox
por: Dao, Myriam, et al.
Publicado: (2021)